Rchr
J-GLOBAL ID:202101014373284046
Update date: Sep. 20, 2024
Hosono Yasuyuki
ホソノ ヤスユキ | Hosono Yasuyuki
Affiliation and department:
Job title:
Professor
Research theme for competitive and other funds (13):
- 2023 - 2027 Development of a novel therapeutic strategy targeting the microenvironment that tolerates the progression of refractory lung cancer
- 2024 - 2026 Novel Animal Models for the Analysis of Tumor-Associated Senescent Cell Spreading
- 2023 - 2026 Prediction of drug efficacies with AI methodologies for the medical application of plasma proteins
- 2024 - 2025 癌・精巣リボヌクレオタンパク質の機能解明と、新規抗がん剤創出
- 2022 - 2025 癌・精巣リボヌクレオタンパク質の機能解明と、新規抗がん剤創出
- 2022 - 2025 Validation and drug development for anti-cancer therapy targeting hemolysis-hemopexin related axis
- 2022 - 2025 固形癌における抗腫瘍薬の薬剤耐性を改善するグルタミン代謝抑制化合物の開発
- 2021 - 2024 Development of therapeutic drugs fro achondroplasia-Examination of FGFR3 inhibitory effects of meclizine hydrochloride
- 2020 - 2024 ヒトとゼブラフィッシュの類似点・相違点を利用した、遺伝子と化合物スクリーニング
- 2018 - 2021 Role of ROR1-mediated caveolae function in cell membrane organization and dynamics
- 2019 - 2020 Promoter analysis of THOR, cancer-testis lncRNA
- 2015 - 2020 Systems analysis of roles of non-coding RNAs in lung cancer development
- 2010 - 2011 肺腺癌のリネジ特異的生存因子であるTTF-1遺伝子の下流分子の探索と機能解明
Show all
Papers (21):
-
Yuichi Miyairi, Bisei Ohkawara, Ayato Sato, Ryusuke Sawada, Hisao Ishii, Hiroyuki Tomita, Taro Inoue, Hiroaki Nakashima, Mikako Ito, Akio Masuda, et al. A class of chemical compounds enhances clustering of muscle nicotinic acetylcholine receptor in cultured myogenic cells. Biochemical and biophysical research communications. 2024. 731. 150400-150400
-
Yuriko N. Koyanagi, Masahiro Nakatochi, Shinichi Namba, Isao Oze, Hadrien Charvat, Akira Narita, Takahisa Kawaguchi, Hiroaki Ikezaki, Asahi Hishida, Megumi Hara, et al. Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Science Advances. 2024. 10. 4
-
Mika Iwai, Taisuke Kajino, Masahiro Nakatochi, Kiyoshi Yanagisawa, Yasuyuki Hosono, Hisanori Isomura, Yukako Shimada, Motoshi Suzuki, Ayumu Taguchi, Takashi Takahashi. Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer. Oncogene. 2022
-
Genta Takemoto, Masaki Matsushita, Takaaki Okamoto, Toshinari Ito, Yuki Matsuura, Chieko Takashima, Toyofumi Fengshi Chen-Yoshikawa, Hiromichi Ebi, Shiro Imagama, Hiroshi Kitoh, et al. Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval Zebrafish. Frontiers in cell and developmental biology. 2021. 9. 694018-694018
-
Yingsong Lin, Masahiro Nakatochi, Yasuyuki Hosono, Hidemi Ito, Yoichiro Kamatani, Akihito Inoko, Hiromi Sakamoto, Fumie Kinoshita, Yumiko Kobayashi, Hiroshi Ishii, et al. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Nature communications. 2020. 11. 1. 3175-3175
more...
Education (2):
- 2007 - 2011 名古屋大学大学院医学系研究科
- 1997 - 2003 名古屋大学医学部医学科
Work history (10):
- 2021/10 - 現在 Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Pharmacology Professor
- 2018/04 - 2021/09 愛知県がんセンター研究所・がん標的治療TR分野・ ユニット長
- 2018/02 - 2018/03 愛知県がんセンター研究所・腫瘍病理学部・室長
- 2013/01 - 2018/01 University of Michigan, Department of Pathology, Postdoctoral Fellow
- 2011/04 - 2012/12 名古屋大学大学院医学系研究科・博士研究員
- 2011/04 - 2012/08 がん研究振興財団・リサーチレジデント
- 2010/04 - 2011/03 日本学術振興会・特別研究員DC2
- 2007/04 - 2011/03 名古屋大学大学院医学系研究科・大学院生
- 2006/04 - 2007/03 仙台厚生病院・呼吸器外科
- 2003/04 - 2006/03 虎の門病院・外科レジデント
Show all
Return to Previous Page